KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Goodwill (2016 - 2025)

Abbott Laboratories' Goodwill history spans 16 years, with the latest figure at $23.1 billion for Q4 2024.

  • For Q4 2024, Goodwill changed N/A year-over-year to $23.1 billion; the TTM value through Dec 2024 reached $23.1 billion, changed N/A, while the annual FY2024 figure was $23.1 billion, N/A changed from the prior year.
  • Goodwill for Q4 2024 was $23.1 billion at Abbott Laboratories, down from $23.3 billion in the prior quarter.
  • Across five years, Goodwill topped out at $23.7 billion in Q4 2020 and bottomed at $22.3 billion in Q3 2022.
  • The 5-year median for Goodwill is $23.3 billion (2023), against an average of $23.2 billion.
  • The largest annual shift saw Goodwill fell 4.29% in 2022 before it grew 4.38% in 2023.
  • A 5-year view of Goodwill shows it stood at $23.7 billion in 2020, then dropped by 2.29% to $23.2 billion in 2021, then dropped by 1.72% to $22.8 billion in 2022, then rose by 2.09% to $23.3 billion in 2023, then dropped by 0.76% to $23.1 billion in 2024.
  • Per Business Quant, the three most recent readings for ABT's Goodwill are $23.1 billion (Q4 2024), $23.3 billion (Q2 2024), and $23.3 billion (Q3 2023).